243 filings
Page 5 of 13
S-3ASR
6951vgwc
24 Mar 21
Automatic shelf registration
4:56pm
RW
o90sd
24 Mar 21
Registration withdrawal request
4:53pm
8-K
l3vrkgag5kh3xzk26ipd
8 Mar 21
Syndax Pharmaceuticals Reports Fourth Quarter 2020 Financial Results and Provides Clinical and Business Update
4:02pm
8-K
3mibaj70bku3t
5 Feb 21
Departure of Directors or Certain Officers
4:30pm
8-K
jeygs4giax
9 Dec 20
Entry into a Material Definitive Agreement
4:05pm
424B5
lpdtyoiupyje5fnfn
9 Dec 20
Prospectus supplement for primary offering
4:02pm
8-K
s4fv 8zo1thd4ofn0
7 Dec 20
Termination of a Material Definitive Agreement
5:23pm
424B5
0pfmro1z
7 Dec 20
Prospectus supplement for primary offering
5:22pm
8-K
ukxju5htosakk 7mll1
2 Nov 20
Syndax Pharmaceuticals Reports Third Quarter 2020 Financial Results and Provides Clinical and Business Update
4:07pm
S-8
zrywetakpofl9
6 Aug 20
Registration of securities for employees
4:18pm
8-K
x0c5owo3
6 Aug 20
Syndax Pharmaceuticals Reports Second Quarter 2020 Financial Results and Provides Clinical and Business Update
4:05pm
8-K
vfeogooesyyge eq8jop
7 Jul 20
Syndax Pharmaceuticals Appoints Daphne Karydas as Chief Financial Officer
7:16am
8-K
w2j2 3jx77fjro9yg
9 Jun 20
Submission of Matters to a Vote of Security Holders
4:02pm
8-K
01jce89s66xdrb7qcxcd
7 May 20
Syndax Pharmaceuticals Reports First Quarter 2020 Financial Results and Provides Clinical and Business Update
4:09pm